相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MOG-related disorders: A new cause of imaging-negative myelitis?
Gabrielle Macaron et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
C. L. de Mol et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning
Elias S. Sotirchos et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Clinical, imaging and follow-up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patients
N. Shor et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary
V. Papp et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea
Jee-Eun Kim et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
Romana Hoeftberger et al.
ACTA NEUROPATHOLOGICA (2020)
Extensive subpial cortical demyelination is specific to multiple sclerosis
Andreas Junker et al.
BRAIN PATHOLOGY (2020)
Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations
Yang Mao-Draayer et al.
NATURE REVIEWS NEUROLOGY (2020)
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
Marius Ringelstein et al.
NEUROLOGY (2020)
International multicenter examination of MOG antibody assays
Markus Reindl et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study
Yoshiki Takai et al.
BRAIN (2020)
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Anthony Traboulsee et al.
LANCET NEUROLOGY (2020)
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
Chao Zhang et al.
LANCET NEUROLOGY (2020)
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
Masayuki Tahara et al.
LANCET NEUROLOGY (2020)
Effectiveness of subcutaneous tocilizumab in neuromyelitis optica spectrum disorders
Itay Lotan et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Prodromal headache in MOG-antibody positive optic neuritis
Susanna Asseyer et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Long-term efficacy of mycophenolate mofetil in myelin oligodendrocyte glycoprotein antibody-associated disorders A prospective study
Shengde Li et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Seizure occurrence in myelin oligodendrocyte glycoprotein antibody-associated disease: A systematic review and meta -analysis
Chun-Hong Shen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
Jae-Won Hyun et al.
FRONTIERS IN NEUROLOGY (2020)
Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders
Seyedamirhosein Motamedi et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Cell-based assays for the detection of MOG antibodies: a comparative study
Matteo Gastaldi et al.
JOURNAL OF NEUROLOGY (2020)
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2020)
FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis With Seizures (FLAMES): Is immunotherapy always needed to put out the fire?
Adrian Budhram et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
Daniel H. Whittam et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders
Meichun Gao et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
Tocilizumab treatment in severe recurrent anti-MOG-associated optic neuritis
Helen Hayward-Koennecke et al.
NEUROLOGY (2019)
Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production
Elizabeth Cotzomi et al.
BRAIN (2019)
Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica
John Soltys et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
S. J. Pittock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
Massimo Filippi et al.
BRAIN (2019)
Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
Frederike C. Oertel et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
Alvaro Cobo-Calvo et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome
A. Budhram et al.
JOURNAL OF NEUROLOGY (2019)
MRI features of demyelinating disease associated with anti-MOG antibodies in adults
Marc Deneve et al.
JOURNAL OF NEURORADIOLOGY (2019)
Devic's index case: A critical reappraisal-AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis?
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Epidemiology of NMOSD in Sweden from 1987 to 2013
Dagur Ingi Jonsson et al.
NEUROLOGY (2019)
In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis
Marco Vabanesi et al.
SCIENTIFIC REPORTS (2019)
Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features
Frederike Cosima Oertel et al.
FRONTIERS IN NEUROLOGY (2019)
Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
Hadas Stiebel-Kalish et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Neuromyelitis optica spectrum disorder Patient experience and quality of life
Janine Beekman et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
Bruce A. C. Cree et al.
LANCET (2019)
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
Mitsuru Watanabe et al.
NEUROLOGY (2019)
Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis
Tim Sinnecker et al.
JAMA NEUROLOGY (2019)
Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008-2018: A nationwide, population-based cohort study
Magnus S. Boesen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
Fiona Tea et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis
Miao-Miao Hou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese
Kotaro Ogawa et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
Takashi Yamamura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
Sophie Hillebrand et al.
ACTA NEUROPATHOLOGICA (2019)
Effectiveness and tolerability of immunosuppressants and monoclonal antibodies in preventive treatment of neuromyelitis optica spectrum disorders: A systematic review and network meta-analysis
Wenjuan Huang et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
Alvaro Cobo-Calvo et al.
JOURNAL OF NEUROLOGY (2019)
Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity
Claudia Chien et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Markus Reindl et al.
NATURE REVIEWS NEUROLOGY (2019)
The history of neuromyelitis optica. Part 2: 'Spinal amaurosis', or how it all began
S. Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody
Divyanshu Dubey et al.
JAMA NEUROLOGY (2019)
Tocilizumab in MOG-antibody spectrum disorder: a case report
G. Novi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
Baptiste Pasquier et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
Sudarshini Ramanathan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Bidirectional degeneration in the visual pathway in neuromyelitis optica spectrum disorder (NMOSD)
De-Cai Tian et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Maria Sepulveda et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Maureen A. Mealy et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Bidirectional degeneration in the visual pathway in neuromyelitis optica spectrum disorder (NMOSD)
De-Cai Tian et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Maria Sepulveda et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Maureen A. Mealy et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study
Sharareh Eskandarieh et al.
ACTA NEUROLOGICA BELGICA (2018)
Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein
Melania Spadaro et al.
ANNALS OF NEUROLOGY (2018)
Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes
Sophie Duignan et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
S. Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
E. C. Tallantyre et al.
JOURNAL OF NEUROLOGY (2018)
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Matthias Baumann et al.
JOURNAL OF NEUROLOGY (2018)
Nationwide epidemiological study of neuromyelitis optica in Japan
Katsuichi Miyamoto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Worldwide prevalence of neuromyelitis optica spectrum disorders
Masahiro Mori et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study
Frederike C. Oertel et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
The current role of MRI in differentiating multiple sclerosis from its imaging mimics
Ruth Geraldes et al.
NATURE REVIEWS NEUROLOGY (2018)
A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica
Karol Estrada et al.
NATURE COMMUNICATIONS (2018)
Disease Course and Treatment Responses in Children With RelapsingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Yael Hacohen et al.
JAMA NEUROLOGY (2018)
Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease
Shahd H. M. Hamid et al.
JAMA NEUROLOGY (2018)
Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence
Jyh Yung Hor et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder
Maureen A. Mealy et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Lower frequency of antibodies to MOG in Brazilian patients with demyelinating diseases: An ethnicity influence?
Regina Maria Papais-Alvarenga et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome
John J. Chen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
Area postrema syndrome Frequency, criteria, and severity in AQP4-IgG-positive NMOSD
Eslam Shosha et al.
NEUROLOGY (2018)
Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients
Winda Kusumadewi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark
Viktoria Papp et al.
NEUROLOGY (2018)
Racial differences in neuromyelitis optica spectrum disorder
Su-Hyun Kim et al.
NEUROLOGY (2018)
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
Nadja Borisow et al.
FRONTIERS IN NEUROLOGY (2018)
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
Andrea Marcinno et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Apheresis therapies for NMOSD attacks A retrospective study of 207 therapeutic interventions
Ingo Kleiter et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Defining distinct features of anti-MOG antibody associated central nervous system demyelination
Martin S. Weber et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature
S. Jarius et al.
JOURNAL OF NEUROLOGY (2017)
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
Maciej Jurynczyk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
Alexis Montcuquet et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
Nadja Borisow et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
Alexis Montcuquet et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
Nadja Borisow et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
The HLA DRB1*03:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio de Janeiro
M. P. Alvarenga et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
Patrick Peschl et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis
S. Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
Zahra Nikoo et al.
JOURNAL OF NEUROLOGY (2017)
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study
Sara Mariotto et al.
JOURNAL OF NEUROLOGY (2017)
Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France
Damien Biotti et al.
JOURNAL OF NEUROLOGY (2017)
Incidence and prevalence of NMOSD in Australia and New Zealand
Wajih Bukhari et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
Jan-Patrick Stellmann et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
Axel Petzold et al.
LANCET NEUROLOGY (2017)
FAILURE OF ALEMTUZUMAB THERAPY TO CONTROL MOG ENCEPHALOMYELITIS
Brigitte Wildemann et al.
NEUROLOGY (2017)
Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder
Divyanshu Dubey et al.
JAMA NEUROLOGY (2017)
Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders
Felix Schmidt et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Painful tonic spasm in neuromyelitis optica spectrum disorders: Prevalence, clinical implications and treatment options
Ju Liu et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Neuromyelitis optica spectrum disorders in Iran
Sharareh Eskandarieh et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Differential diagnosis of neuromyelitis optica spectrum disorders
Sung-Min Kim et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2017)
Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G
Xiaoming Yao et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G
Xiaoming Yao et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
Bo Chen et al.
SCIENTIFIC REPORTS (2017)
MRI evaluation of thalamic volume differentiates MS from common mimics
Andrew J. Solomon et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder
Nasrin Asgari et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica
Lukmanee Tradtrantip et al.
ACTA NEUROPATHOLOGICA (2017)
Microstructural visual system changes in AQP4-antibody-seropositive NMOSD
Frederike C. Oertel et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
Ryo Ogawa et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis
Maciej Jurynczyk et al.
BRAIN (2017)
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
Ingo Kleiter et al.
ANNALS OF NEUROLOGY (2016)
Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic
Remi A. Kessler et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2016)
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study
Tetsuya Akaishi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
Sudarshini Ramanathan et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging
Yeliz Pekcevik et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients
Sasitorn Siritho et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
Ingo Kleiter et al.
NEUROTHERAPEUTICS (2016)
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients
Sasitorn Siritho et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging
Yeliz Pekcevik et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
Sudarshini Ramanathan et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen
Silke Kinzel et al.
ACTA NEUROPATHOLOGICA (2016)
Epidemiology of Aquaporin-4 Autoimmunity and Neuromyelitis Optica Spectrum
Eoin P. Flanagan et al.
ANNALS OF NEUROLOGY (2016)
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study
F. Pache et al.
EUROPEAN RADIOLOGY (2016)
Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel
Livnat Brill et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Vitamin D level status in Thai neuromyelitis optica patients
Jiraporn Jitprapaikulsan et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Serum 25-hydroxyvitamin D3 is associated with disease status in patients with neuromyelitis optica spectrum disorders in south China
Yilong Shan et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression
Ziyan Shi et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G
Christian M. Felix et al.
JOURNAL OF NEUROINFLAMMATION (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
Florence Pache et al.
JOURNAL OF NEUROINFLAMMATION (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2016)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes
Maria Sepulveda et al.
JOURNAL OF NEUROLOGY (2016)
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Patrick Waters et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case
Sven Jarius et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
INFLAMMATORY DEMYELINATION WITHOUT ASTROCYTE LOSS IN MOG ANTIBODY-POSITIVE NMOSD
Justine J. Wang et al.
NEUROLOGY (2016)
Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4
Sharon A. Sagan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease
Anne-Christine Flach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
Yaping Yan et al.
SCIENCE CHINA-LIFE SCIENCES (2016)
Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders A Systematic Review and Meta-analysis
Valentina Damato et al.
JAMA NEUROLOGY (2016)
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case
Sven Jarius et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Immunoadsorption in patients with neuromyelitis optica spectrum disorder
Simon Faissner et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD
Carsten Finke et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Restoring immune tolerance in neuromyelitis optica Part I
Larry Steinman et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Restoring immune tolerance in neuromyelitis optica Part II
Amit Bar-Or et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
Velina S. Chavarro et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Mutagenesis of the Aquaporin 4 Extracellular Domains Defines Restricted Binding Patterns of Pathogenic Neuromyelitis Optica IgG
Gregory P. Owens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry
H. -Christian von Buedingen et al.
JOURNAL OF CELL BIOLOGY (2015)
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab
Maureen A. Mealy et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Intravenous immunoglobulin may reduce relapse frequency in neuromyelitis optica
Shanthi Viswanathan et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75
Markus Krumbholz et al.
JOURNAL OF NEUROLOGY (2015)
Analysis of the treatment of neuromyelitis optica
Jose Torres et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Human leukocyte antigen association with neuromyelitis optica in a south Indian population
Lekha Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Role of membrane complement regulators in neuromyelitis optica
Samira Saadoun et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
J. L. Bennett et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Reduced serum vitamin D levels in neuromyelitis optica
Erdem Tuzun et al.
NEUROLOGICAL SCIENCES (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
MRI characteristics of neuromyelitis optica spectrum disorder An international update
Ho Jin Kim et al.
NEUROLOGY (2015)
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder
Stephane Kremer et al.
JAMA NEUROLOGY (2015)
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Marius Ringelstein et al.
JAMA NEUROLOGY (2015)
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders
Eoin P. Flanagan et al.
JAMA NEUROLOGY (2015)
Human leukocyte antigen association with neuromyelitis optica in a south Indian population
Lekha Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Role of membrane complement regulators in neuromyelitis optica
Samira Saadoun et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
J. L. Bennett et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder
Kerry Mutch et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica
Shin Iida et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica
Melina V. Jones et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease
Romana Hoeftberger et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
Sung-Min Kim et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
B lymphocytes in neuromyelitis optica
Jeffrey L. Bennett et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
Melania Spadaro et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Conventional and Advanced Imaging in Neuromyelitis Optica
Y. Barnett et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis
Maarten J. Titulaer et al.
ANNALS OF NEUROLOGY (2014)
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Ramnath Santosh Ramanathan et al.
BMC NEUROLOGY (2014)
The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
Claudia F. Lucchinetti et al.
BRAIN PATHOLOGY (2014)
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
S. Jarius et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported
Axel Petzold et al.
JOURNAL OF NEUROLOGY (2014)
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
Corinna Trebst et al.
JOURNAL OF NEUROLOGY (2014)
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
M. Ringelstein et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients
Liene Elsone et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
So-Young Huh et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Visual evoked potentials in neuromyelitis optica and its spectrum disorders
Marius Ringelstein et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset
N. Collongues et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders
Felipe von Glehn et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
Liene Elsone et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India
Lekha Pandit et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Pain in neuromyelitis optica-prevalence, pathogenesis and therapy
Monika Bradl et al.
NATURE REVIEWS NEUROLOGY (2014)
Protective environmental factors for neuromyelitis optica
Jennifer Graves et al.
NEUROLOGY (2014)
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki et al.
NEUROLOGY (2014)
Low Levels of Vitamin D in Neuromyelitis Optica Spectrum Disorder: Association with Disease Disability
Ju-Hong Min et al.
PLOS ONE (2014)
Seroprevalence of Aquaporin-4-IgG in a Northern California Population Representative Cohort of Multiple Sclerosis
Sean J. Pittock et al.
JAMA NEUROLOGY (2014)
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
Joanna Kitley et al.
JAMA NEUROLOGY (2014)
Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder
So-Young Huh et al.
JAMA NEUROLOGY (2014)
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica Multicenter Study of Treatment Efficacy
Maureen A. Mealy et al.
JAMA NEUROLOGY (2014)
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
Samira Saadoun et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
Sudarshini Ramanathan et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica
Tatsuro Misu et al.
ACTA NEUROPATHOLOGICA (2013)
Enzymatic Deglycosylation Converts Pathogenic Neuromyelitis Optica Anti-Aquaporin-4 Immunoglobulin G into Therapeutic Antibody
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2013)
Cognitive Impairment and Cortical Degeneration in Neuromyelitis Optica
Etsuji Saji et al.
ANNALS OF NEUROLOGY (2013)
Aquaporin-4 Antibodies (NMO-IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
Sven Jarius et al.
BRAIN PATHOLOGY (2013)
Efficacy of Intravenous Cyclophosphamide Therapy for Neuromyelitis Optica Spectrum Disorder
Hiroaki Yaguchi et al.
INTERNAL MEDICINE (2013)
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica
Hua Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
Su-Hyun Kim et al.
JOURNAL OF CLINICAL NEUROLOGY (2013)
Distinction and Temporal Stability of Conformational Epitopes on Myelin Oligodendrocyte Glycoprotein Recognized by Patients with Different Inflammatory Central Nervous System Diseases
Marie C. Mayer et al.
JOURNAL OF IMMUNOLOGY (2013)
Neuromyelitis Optica IgG Causes Placental Inflammation and Fetal Death
Samira Saadoun et al.
JOURNAL OF IMMUNOLOGY (2013)
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica
Hiroshi Kuroda et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica
S. Jarius et al.
JOURNAL OF NEUROLOGY (2013)
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom
Anu Jacob et al.
JOURNAL OF NEUROLOGY (2013)
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study
Philippe Cabre et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status
Satoshi Yoshimura et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
HOW OFTEN DOES RESPIRATORY FAILURE OCCUR IN NEUROMYELITIS OPTICA?
Liene Elsone et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
Joanna Kitley et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Sean J. Pittock et al.
LANCET NEUROLOGY (2013)
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis
Chao Quan et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica
K. Rostasy et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
The effect of intravenous immunoglobulin on neuromyelitis optica
M. J. Magraner et al.
NEUROLOGIA (2013)
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient
Nasrin Asgari et al.
NEUROLOGY (2013)
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution
Lucy Matthews et al.
NEUROLOGY (2013)
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica
Elias S. Sotirchos et al.
NEUROLOGY (2013)
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People
Fahmy Aboul-Enein et al.
PLOS ONE (2013)
Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica
Marcelo Matiello et al.
JAMA NEUROLOGY (2013)
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
Ilya Ayzenberg et al.
JAMA NEUROLOGY (2013)
Therapeutic Cleavage of Anti-Aquaporin-4 Autoantibody in Neuromyelitis Optica by an IgG-Selective Proteinase
Lukmanee Tradtrantip et al.
MOLECULAR PHARMACOLOGY (2013)
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Julien Ratelade et al.
ACTA NEUROPATHOLOGICA (2012)
Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2012)
Neutrophil Protease Inhibition Reduces Neuromyelitis Optica-Immunoglobulin G-Induced Damage in Mouse Brain
Samira Saadoun et al.
ANNALS OF NEUROLOGY (2012)
Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
Michel Varrin-Doyer et al.
ANNALS OF NEUROLOGY (2012)
Lack of Response to Pulse Cyclophosphamide in Neuromyelitis Optica: Evaluation of 7 Patients
Denis B. Bichuetti et al.
ARCHIVES OF NEUROLOGY (2012)
Association Between Paroxysmal Tonic Spasms and Neuromyelitis Optica
Nida Usmani et al.
ARCHIVES OF NEUROLOGY (2012)
Association of Neuromyelitis Optica With Severe and Intractable Pain
Peiqing Qian et al.
ARCHIVES OF NEUROLOGY (2012)
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
Joanna Kitley et al.
BRAIN (2012)
Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: Case report and review of the literature
S. Jarius et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2012)
The prevalence of neuromyelitis optica in South East Wales
M. Cossburn et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica
Lukmanee Tradtrantip et al.
FASEB JOURNAL (2012)
HyperCKemia Related to the Initial and Recurrent Attacks of Neuromyelitis Optica
Shoko Deguchi et al.
INTERNAL MEDICINE (2012)
A Small-molecule Screen Yields Idiotype-specific Blockers of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4
Puay-Wah Phuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes
Andrea Rossi et al.
JOURNAL OF CELL SCIENCE (2012)
Cerebrospinal Fluid BAFF and APRIL Levels in Neuromyelitis Optica and Multiple Sclerosis Patients During Relapse
Honghao Wang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
S. Jarius et al.
JOURNAL OF NEUROLOGY (2012)
Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane
Luciana Melamud et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Interleukin 17 gene polymorphism is associated with anti-aquaporin 4 antibody-positive neuromyelitis optica in the Southern Han Chinese - A case control study
Honghao Wang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Testing for antibodies to human aquaporin-4 by ELISA: Sensitivity, specificity, and direct comparison with immunohistochemistry
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease
Dean M. Wingerchuk et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature
S. Jarius et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
The differential diagnosis of longitudinally extensive transverse myelitis
J. L. Kitley et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4
Woojun Kim et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence
Anu Jacob et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
RECURRENT HYPERCKEMIA WITH NORMAL MUSCLE BIOPSY IN A PEDIATRIC PATIENT WITH NEUROMYELITIS OPTICA
Massimiliano Di Filippo et al.
NEUROLOGY (2012)
Serologic diagnosis of NMO A multicenter comparison of aquaporin-4-IgG assays
P. J. Waters et al.
NEUROLOGY (2012)
T-CELL REACTIVITY AGAINST AQP4 IN NEUROMYELITIS OPTICA
Adi Vaknin-Dembinsky et al.
NEUROLOGY (2012)
Myasthenia gravis and neuromyelitis optica spectrum disorder A multicenter study of 16 patients
M. I. Leite et al.
NEUROLOGY (2012)
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis
Tim Sinnecker et al.
NEUROLOGY (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions
Samira Saadoun et al.
NEUROREPORT (2012)
White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica
Frederic Blanc et al.
PLOS ONE (2012)
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Shannon R. Hinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Treatment of neuromyelitis optica: Review and recommendations
Dorlan J. Kimbrough et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2012)
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
Anke Stroet et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Hua Zhang et al.
ANNALS OF NEUROLOGY (2011)
Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica
Su-Hyun Kim et al.
ARCHIVES OF NEUROLOGY (2011)
Evidence against Cellular Internalization in Vivo of NMO-IgG, Aquaporin-4, and Excitatory Amino Acid Transporter 2 in Neuromyelitis Optica
Julien Ratelade et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
H. H. Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
HLA-DPB1*0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in Southern Han Chinese
Honghao Wang et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Simone Mader et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population
R. Deschamps et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders
Sven Jarius et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Pain in neuromyelitis optica and its effect on quality of life A cross-sectional study
Y. Kanamori et al.
NEUROLOGY (2011)
Azathioprine Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
C. Costanzi et al.
NEUROLOGY (2011)
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H. L. Pellkofer et al.
NEUROLOGY (2011)
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Mary Anne Dooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjogren's syndrome
Klaus-Peter Wandinger et al.
ARTHRITIS AND RHEUMATISM (2010)
Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells
Makoto Kinoshita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis
Hideto Nakajima et al.
BMC NEUROLOGY (2010)
Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis
Nathan P. Young et al.
BRAIN (2010)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders
Sven Jarius et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica
Masahiko Nakamura et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis
Sven Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis
Doralina Guimaraes Brum et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population
Adi Vaknin-Dembinsky et al.
MULTIPLE SCLEROSIS (2010)
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Sven Jarius et al.
NATURE REVIEWS NEUROLOGY (2010)
Neuromyelitis Optica: Pathogenicity of Patient Immunoglobulin In Vivo
Monika Bradl et al.
ANNALS OF NEUROLOGY (2009)
Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica
Jeffrey L. Bennett et al.
ANNALS OF NEUROLOGY (2009)
Prediction of Neuromyelitis Optica Attack Severity by Quantitation of Complement-Mediated Injury to Aquaporin-4-Expressing Cells
Shannon R. Hinson et al.
ARCHIVES OF NEUROLOGY (2009)
Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2009)
Neuromyelitis optica: Passive transfer to rats by human immunoglobulin
Makoto Kinoshita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis
Katherine A. McLaughlin et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells
Wendy A. Goodman et al.
JOURNAL OF IMMUNOLOGY (2009)
Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study
Lidia Sabater et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
Akiyuki Uzawa et al.
JOURNAL OF NEUROLOGY (2009)
Two cases of benign neuromyelitis optica in patients with celiac disease
R. Bergamaschi et al.
JOURNAL OF NEUROLOGY (2009)
An epidemiological study of neuromyelitis optica in Cuba
Jose A. Cabrera-Gomez et al.
JOURNAL OF NEUROLOGY (2009)
Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker
T. Misu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Is neuromyelitis optica associated with human leukocyte antigen?
H. Zephir et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
M. Bonnan et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
A CASE OF NMO SEROPOSITIVE FOR AQUAPORIN-4 ANTIBODY MORE THAN 10 YEARS BEFORE ONSET
S. Nishiyama et al.
NEUROLOGY (2009)
Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders
T. Matsushita et al.
TISSUE ANTIGENS (2009)
Interactive Case Report A woman with acute myelopathy in pregnancy: case outcome
Reinhard Reuss et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Treatment of Neuromyelitis Optica With Rituximab Retrospective Analysis of 25 Patients
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2008)
Aquaporin-4 antibodies in neuromyelitis Optica and longitudinally extensive transverse myelitis
Patrick Waters et al.
ARCHIVES OF NEUROLOGY (2008)
Persistence of Immunopathological and Radiological Traits in Multiple Sclerosis
Fatima B. Koenig et al.
ARCHIVES OF NEUROLOGY (2008)
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
S. Jarius et al.
BRAIN (2008)
Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
Shannon R. Hinson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment
Thierry Vincent et al.
JOURNAL OF IMMUNOLOGY (2008)
Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4
S. Jarius et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations
T. Takahashi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
CNS aquaporin-4 autoimmunity in children
A. McKeon et al.
NEUROLOGY (2008)
IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells
Thomas Korn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica
Sven Jarius et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
S. R. Hinson et al.
NEUROLOGY (2007)
Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis
S. Watanabe et al.
MULTIPLE SCLEROSIS (2007)
Neuromyelitis optica with clinical and histopathological involvement of the brain
G. J. D. Hengstman et al.
MULTIPLE SCLEROSIS (2007)
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Toshiyuki Takahashi et al.
BRAIN (2007)
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
Shanu F. Roemer et al.
BRAIN (2007)
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
T. Misu et al.
BRAIN (2007)
Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
F. Paul et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
Kevin C. O'Connor et al.
NATURE MEDICINE (2007)
The spectrum of neuromyelitis optica
Dean M. Wingerchuk et al.
LANCET NEUROLOGY (2007)
Study of mitoxantrone for the treatment of recurrent neuromyelitis Optica (Devic disease)
Bianca Weinstock-Guttman et al.
ARCHIVES OF NEUROLOGY (2006)
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression
Sean J. Pittock et al.
ARCHIVES OF NEUROLOGY (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis
BG Weinshenker et al.
ANNALS OF NEUROLOGY (2006)
Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica
T Misu et al.
NEUROLOGY (2005)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
T Ishizu et al.
BRAIN (2005)
Activation of humoral immunity and eosinophils in neuromyelitis optica
J Correale et al.
NEUROLOGY (2004)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function
P Vourc'h et al.
BRAIN RESEARCH REVIEWS (2004)
The molecular basis of water transport in the brain
M Amiry-Moghaddam et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Subpial demyelination in the cerebral cortex of multiple sclerosis patients
L Bo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)
分享论文
